CAXTON CORP 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 4:01 pm Sale |
2021-12-31 | 13G | CTI BioPharma Corp. CTIC |
CAXTON CORP | 2,239,300 2.300% |
-1,510,590![]() (-40.28%) |
Filing |
2021-02-16 4:23 pm Sale |
2020-12-31 | 13G | CTI BioPharma Corp. CTIC |
CAXTON CORP | 3,749,890 5.100% |
-737,427![]() (-16.43%) |
Filing |
2020-10-01 5:55 pm Purchase |
2020-02-13 | 13G | CTI BioPharma Corp. CTIC |
CAXTON CORP | 4,487,317 6.100% |
4,487,317![]() (New Position) |
Filing |